Page last updated: 2024-08-25

4-o-methyl-12-o-tetradecanoylphorbol 13-acetate and Atherosclerosis

4-o-methyl-12-o-tetradecanoylphorbol 13-acetate has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Al-Sharea, A; Choi, JSY; de Haan, JB; Jandeleit-Dahm, K; Mukhamedova, N; Murphy, AJ; Ritchie, RH; Sharma, A; Simpson, DS; Stefanovic, N; Sviridov, D; Vince, JE1

Other Studies

1 other study(ies) available for 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate and Atherosclerosis

ArticleYear
Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis.
    Diabetes, 2021, Volume: 70, Issue:3

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Blood Glucose; Cells, Cultured; Fluorescent Antibody Technique; Glucose; Humans; Immunohistochemistry; Inflammasomes; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Tetradecanoylphorbol Acetate; THP-1 Cells; Tumor Necrosis Factor-alpha

2021